Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move
across top level links and expand / close menus in sub levels. Up and Down arrows will open main level
menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab
will move on to the next part of the site rather than go through menu items.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Join the brightest minds in regulatory at the annual Regulatory Convergence. See the global regulatory community in action. Intensive workshops. Topical sessions. Meet ups with regulators. This is where it all comes together.
For 20 years, our flagship publication, Fundamentals of US Regulatory Affairs, has been giving regulatory professionals the insights and answers they need, right at their fingertips.
There are hundreds of RAC testing centers available worldwide. Any of the four RAC exams (US, EU, CAN or Global) may be taken at any location. Find an upcoming exam at a location near you.
Posted 27 February 2012 | By Alexander Gaffney, RAC
A trio of Congressional hearings the week of 27 February will explore the proposed budget of the US Food and Drug Administration (FDA), the proposed budget of the US Department of Health and Human Services (DHHS) and prescription drug diversion.
On 29 February 2012, FDA Commissioner Margaret Hamburg will appear before the US House Committee on Appropriations. Hamburg will be joined by FDA Assistant Commissioner for Budget Patrick McGarey and Deputy Assistant Secretary for Budget Norris Cochran.
On 1 March 2012, DHHS Secretary Kathleen Sebelius will appear before the US House Energy and Commerce Committee to discuss the Fiscal Year 2013 budget for DHHS, which includes FDA's budget.
Also on 1 March 2012, the House Energy and Commerce Committee will hold a hearing on the issue of prescription drug diversion and how to mitigate the problem. Witnesses have not yet been announced by the committee.
Budget Hearing - Department of Health and Human Services, Food and Drug Administration - Commissioner
House Energy and Commerce Committee - The FY 2013 HHS Budget
House Energy and Commerce Committee - Prescription Drug Diversion: Combating the Scourge
Tags: Pharamaceutical, Diversion, E&C, Energy and Commerce, Request, Proposed Budget, Fiscal Year 2013, Prescription, FY2013, Budget, Hearing, Latest News, DHHS, Congress, drug
Regulatory Focus newsletters
All the biggest regulatory news and happenings.
This article provides a variety of websites with important information on recent changes to FDA guidances and tables ...